Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2407

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models ; volume:16 ; number:1 ; day:14 ; month:7 ; year:2016 ; pages:1-12 ; date:12.2016
BMC cancer ; 16, Heft 1 (14.7.2016), 1-12, 12.2016

Creator: Phelan, J. P.

Contributor: Reen, F. J.
Dunphy, N.
O’Connor, R.
O’Gara, F.
SpringerLink (Online service)

DOI: 10.1186/s12885-016-2528-2

URN: urn:nbn:de:1111-2016081423392

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Phelan, J. P.
Reen, F. J.
Dunphy, N.
O’Connor, R.
O’Gara, F.
SpringerLink (Online service)

Other Objects (12)

Acid affairs in anti-tumour immunity

Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth

Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response

Glutarate regulates T cell metabolism and anti-tumour immunity

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity

Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response

Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells

Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity

Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy

Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity

Mechanisms of HIF-driven immunosuppression in tumour microenvironment

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

Acid affairs in anti-tumour immunity

Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth

Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response

Glutarate regulates T cell metabolism and anti-tumour immunity

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity

Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response

Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells

Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity

Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy

Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity

Mechanisms of HIF-driven immunosuppression in tumour microenvironment

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

Acid affairs in anti-tumour immunity

Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth

Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response

Glutarate regulates T cell metabolism and anti-tumour immunity

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity

Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response

Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells

Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity

Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy

Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity

Mechanisms of HIF-driven immunosuppression in tumour microenvironment

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Bile acids destabilise HIF-1α and promote anti-tumour phenotypes in cancer cell models

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Acid affairs in anti-tumour immunity

Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth

Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response

Glutarate regulates T cell metabolism and anti-tumour immunity

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity

Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response

Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells

Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity

Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy

Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity

Mechanisms of HIF-driven immunosuppression in tumour microenvironment

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

Acid affairs in anti-tumour immunity

Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth

Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response

Glutarate regulates T cell metabolism and anti-tumour immunity

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity

Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response

Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells

Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity

Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy

Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity

Mechanisms of HIF-driven immunosuppression in tumour microenvironment

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

Acid affairs in anti-tumour immunity

Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth

Fractionated Radiotherapy with 3 x 8 Gy Induces Systemic Anti-Tumour Responses and Abscopal Tumour Inhibition without Modulating the Humoral Anti-Tumour Response

Glutarate regulates T cell metabolism and anti-tumour immunity

Gasdermin: a novel therapeutic target for tumour treatment by activating anti-tumour immunity

Inhibiting glucocorticoid receptor signalling in tumour-associated macrophages for anti-tumour immune response

Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells

Tumour-retained activated CCR7+ dendritic cells are heterogeneous and regulate local anti-tumour cytolytic activity

Small tumour microparticle enhances drug delivery efficiency and therapeutic antitumour efficacy

Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity

Mechanisms of HIF-driven immunosuppression in tumour microenvironment

Isobutyric acid enhances the anti-tumour effect of anti-PD-1 antibody

Related objects

Reset password